Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STAY-LEAN
NCT06854614Phase 4Active, not recruiting
- Sponsor
- Cleveland Clinic
- Start
- Mar 2025
- Primary completion
- Apr 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tirzepatide, semaglutide, phentermine + topiramate, naltrexone + bupropion in obesity, sponsored by Cleveland Clinic. Started Mar 2025; status: active, not recruiting.
02
Drugs
03
Conditions
obesity
Beyond the preview
Go deeper on NCT06854614.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06854614.